Cervical cancer screening programs in Latin America: current recommendations for facing elimination challenges.
Objective. To describe current cervical cancer screening program guidelines in Latin America. Materials and methods. We searched official recommendations for the general population and women living with HIV (WLHIV) by reviewing official sources from 19 countries; these data were supplemented with a...
| Publicado en: | Salud Pública de México Vol. 64; no. 4; pp. 415 - 424 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artículo |
| Publicado: |
Instituto Nacional de Salud Publica
Jul/Aug2022
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=lth&AN=157918260&site=ehost-live header: @attributes: shortDbName: lth uiTerm: 157918260 longDbName: MedicLatina uiTag: AN controlInfo: bkinfo: jinfo: jid: 00363634 7LC jtl: Salud Pública de México issn: 00363634 maglogo: N pubinfo: dt: Jul/Aug2022 vid: 64 iid: 4 pid: 20870 pub: Instituto Nacional de Salud Publica artinfo: ui: 157918260 10.21149/13204 ppf: 415 ppct: 9 formats: fmt: @attributes: type: P size: 1.2MB tig: atl: Cervical cancer screening programs in Latin America: current recommendations for facing elimination challenges. aug: au: Fernández-Deaza, Ginna Caicedo-Martinez, Maria Serrano, Beatriz Roura, Esther Castillo, Juan Sebastián de Sanjose, Silvia Bruni, Laia Murillo, Raúl affil: Centro Javeriano de Oncología, Hospital Universitario San Ignacio. Bogota, Colombia Cancer Epidemiology Research Program, Institut Català d'Oncologia, IDIBELL, L'Hospitalet de Llobregat. Barcelona, Spain Centro de Investigación Biomédica en Red, Epidemiología y Salud Pública. Madrid, Spain Facultad de Medicina, Pontificia Universidad Javeriana. Bogota, Colombia Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health. USA Early Detection, Prevention & Infection Branch, International Agency for Research on Cancer. Lyon, France su: Early detection of cancer Cervical cancer HIV-positive women Costa Rica sug: subj: Costa Rica Early detection of cancer Cervical cancer HIV-positive women keyword: HIV Latin America mass screening papillomavirus infections public policy uterine cervical neoplasms América Latina infecciones por papilomavirus neoplasias del cuello uterino política pública tamizaje masivo VIH ab: Objective. To describe current cervical cancer screening program guidelines in Latin America. Materials and methods. We searched official recommendations for the general population and women living with HIV (WLHIV) by reviewing official sources from 19 countries; these data were supplemented with a consultation carried out by the WHO with the Ministries of Health. Results. Screening policies vary significantly in regard to target populations, primary tests, and screening intervals. Sixteen countries have recently updated their recommendations; however, cytology remains the primary screening test for most countries. Eleven countries have introduced HPV tests, and eight countries have implemented screen-and-treat algorithms; only three countries have developed evidence-based guidelines. All countries but Costa Rica have specific recommendations for WLHIV. Conclusions. Although most countries have updated their screening policies, only a few are properly aligned with the WHO elimination strategy. Recommendations for WLHIV require better integration with cervical cancer screening programs. Objetivo. Describir directrices vigentes en los programas de tamizaje de cáncer de cuello uterino en Latinoamérica. Material y métodos. Se buscaron recomendaciones oficiales en instituciones de gobierno de 19 países, tanto para la población general como para mujeres viviendo con VIH (MVIH). Se complementó la información mediante consulta de la OMS a los Ministerios de Salud. Resultados. Las recomendaciones varían ampliamente entre países respecto a población objeto, pruebas e intervalos de tamizaje. Dieciséis países tienen recomendaciones actualizadas; sin embargo, la citología continúa siendo prueba primaria en la mayoría. Once países introdujeron las pruebas de VPH y ocho tienen estrategias de ver y tratar. Todos los países, excepto Costa Rica, tienen recomendaciones específicas para MVIH. Conclusión. A pesar de recientes actualizaciones, pocos países tienen abordajes adecuadamente alineados con la estrategia de eliminación de la OMS. Las recomendaciones para MVIH requieren mejor integración con los programas de tamizaje. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: Y custom: Copyright of Salud Pública de México is the property of Instituto Nacional de Salud Publica and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. item: Salud Pública de México holder: Instituto Nacional de Salud Publica dt: @attributes: year: 2022 holdings: @attributes: islocal: N |
|---|